1 Market Overview

1.1 Product Overview and Scope of Biopharmaceuticals

1.2 Classification of Biopharmaceuticals by Type

1.2.1 Overview: Global Biopharmaceuticals Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Biopharmaceuticals Revenue Market Share by Type in 2021

1.2.3 Monoclonal Antibodies

1.2.4 Interferon

1.2.5 Colony-Stimulating Factor

1.2.6 Erythropoietin

1.2.7 Insulin

1.2.8 Vaccines

1.2.9 Growth Hormones

1.2.10 Others

1.3 Global Biopharmaceuticals Market by Application

1.3.1 Overview: Global Biopharmaceuticals Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Cardiovascular

1.3.5 Hemophilia

1.3.6 Others

1.4 Global Biopharmaceuticals Market Size & Forecast

1.5 Global Biopharmaceuticals Market Size and Forecast by Region

1.5.1 Global Biopharmaceuticals Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Biopharmaceuticals Market Size by Region, (2017-2022)

1.5.3 North America Biopharmaceuticals Market Size and Prospect (2017-2028)

1.5.4 Europe Biopharmaceuticals Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Biopharmaceuticals Market Size and Prospect (2017-2028)

1.5.6 South America Biopharmaceuticals Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Biopharmaceuticals Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Biopharmaceuticals Market Drivers

1.6.2 Biopharmaceuticals Market Restraints

1.6.3 Biopharmaceuticals Trends Analysis

2 Company Profiles

2.1 Roche

2.1.1 Roche Details

2.1.2 Roche Major Business

2.1.3 Roche Biopharmaceuticals Product and Solutions

2.1.4 Roche Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Roche Recent Developments and Future Plans

2.2 Amgen

2.2.1 Amgen Details

2.2.2 Amgen Major Business

2.2.3 Amgen Biopharmaceuticals Product and Solutions

2.2.4 Amgen Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Amgen Recent Developments and Future Plans

2.3 AbbVie

2.3.1 AbbVie Details

2.3.2 AbbVie Major Business

2.3.3 AbbVie Biopharmaceuticals Product and Solutions

2.3.4 AbbVie Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 AbbVie Recent Developments and Future Plans

2.4 Sanofi-Aventis

2.4.1 Sanofi-Aventis Details

2.4.2 Sanofi-Aventis Major Business

2.4.3 Sanofi-Aventis Biopharmaceuticals Product and Solutions

2.4.4 Sanofi-Aventis Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Sanofi-Aventis Recent Developments and Future Plans

2.5 Johnson & Johnson

2.5.1 Johnson & Johnson Details

2.5.2 Johnson & Johnson Major Business

2.5.3 Johnson & Johnson Biopharmaceuticals Product and Solutions

2.5.4 Johnson & Johnson Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Johnson & Johnson Recent Developments and Future Plans

2.6 Pfizer

2.6.1 Pfizer Details

2.6.2 Pfizer Major Business

2.6.3 Pfizer Biopharmaceuticals Product and Solutions

2.6.4 Pfizer Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Pfizer Recent Developments and Future Plans

2.7 Novo Nordisk

2.7.1 Novo Nordisk Details

2.7.2 Novo Nordisk Major Business

2.7.3 Novo Nordisk Biopharmaceuticals Product and Solutions

2.7.4 Novo Nordisk Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Novo Nordisk Recent Developments and Future Plans

2.8 Eli Lilly

2.8.1 Eli Lilly Details

2.8.2 Eli Lilly Major Business

2.8.3 Eli Lilly Biopharmaceuticals Product and Solutions

2.8.4 Eli Lilly Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Eli Lilly Recent Developments and Future Plans

2.9 Novartis

2.9.1 Novartis Details

2.9.2 Novartis Major Business

2.9.3 Novartis Biopharmaceuticals Product and Solutions

2.9.4 Novartis Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Novartis Recent Developments and Future Plans

2.10 Merck

2.10.1 Merck Details

2.10.2 Merck Major Business

2.10.3 Merck Biopharmaceuticals Product and Solutions

2.10.4 Merck Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Merck Recent Developments and Future Plans

2.11 Sun

2.11.1 Sun Details

2.11.2 Sun Major Business

2.11.3 Sun Biopharmaceuticals Product and Solutions

2.11.4 Sun Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Sun Recent Developments and Future Plans

2.12 3sbio

2.12.1 3sbio Details

2.12.2 3sbio Major Business

2.12.3 3sbio Biopharmaceuticals Product and Solutions

2.12.4 3sbio Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 3sbio Recent Developments and Future Plans

2.13 Changchun High Tech

2.13.1 Changchun High Tech Details

2.13.2 Changchun High Tech Major Business

2.13.3 Changchun High Tech Biopharmaceuticals Product and Solutions

2.13.4 Changchun High Tech Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Changchun High Tech Recent Developments and Future Plans

2.14 CP Guojian

2.14.1 CP Guojian Details

2.14.2 CP Guojian Major Business

2.14.3 CP Guojian Biopharmaceuticals Product and Solutions

2.14.4 CP Guojian Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 CP Guojian Recent Developments and Future Plans

2.15 Biotech

2.15.1 Biotech Details

2.15.2 Biotech Major Business

2.15.3 Biotech Biopharmaceuticals Product and Solutions

2.15.4 Biotech Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Biotech Recent Developments and Future Plans

2.16 Gelgen

2.16.1 Gelgen Details

2.16.2 Gelgen Major Business

2.16.3 Gelgen Biopharmaceuticals Product and Solutions

2.16.4 Gelgen Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Gelgen Recent Developments and Future Plans

2.17 Innovent

2.17.1 Innovent Details

2.17.2 Innovent Major Business

2.17.3 Innovent Biopharmaceuticals Product and Solutions

2.17.4 Innovent Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Innovent Recent Developments and Future Plans

2.18 Dong Bao

2.18.1 Dong Bao Details

2.18.2 Dong Bao Major Business

2.18.3 Dong Bao Biopharmaceuticals Product and Solutions

2.18.4 Dong Bao Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Dong Bao Recent Developments and Future Plans

2.19 Ganlee

2.19.1 Ganlee Details

2.19.2 Ganlee Major Business

2.19.3 Ganlee Biopharmaceuticals Product and Solutions

2.19.4 Ganlee Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 Ganlee Recent Developments and Future Plans

2.20 United Laboratories

2.20.1 United Laboratories Details

2.20.2 United Laboratories Major Business

2.20.3 United Laboratories Biopharmaceuticals Product and Solutions

2.20.4 United Laboratories Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.20.5 United Laboratories Recent Developments and Future Plans

2.21 SANDOZ (NOVARTIS)

2.21.1 SANDOZ (NOVARTIS) Details

2.21.2 SANDOZ (NOVARTIS) Major Business

2.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Product and Solutions

2.21.4 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.21.5 SANDOZ (NOVARTIS) Recent Developments and Future Plans

2.22 Teva Pharmaceutical

2.22.1 Teva Pharmaceutical Details

2.22.2 Teva Pharmaceutical Major Business

2.22.3 Teva Pharmaceutical Biopharmaceuticals Product and Solutions

2.22.4 Teva Pharmaceutical Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.22.5 Teva Pharmaceutical Recent Developments and Future Plans

2.23 Hospira （Pfizer）

2.23.1 Hospira （Pfizer） Details

2.23.2 Hospira （Pfizer） Major Business

2.23.3 Hospira （Pfizer） Biopharmaceuticals Product and Solutions

2.23.4 Hospira （Pfizer） Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.23.5 Hospira （Pfizer） Recent Developments and Future Plans

2.24 MYLAN

2.24.1 MYLAN Details

2.24.2 MYLAN Major Business

2.24.3 MYLAN Biopharmaceuticals Product and Solutions

2.24.4 MYLAN Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.24.5 MYLAN Recent Developments and Future Plans

2.25 Sun pharma

2.25.1 Sun pharma Details

2.25.2 Sun pharma Major Business

2.25.3 Sun pharma Biopharmaceuticals Product and Solutions

2.25.4 Sun pharma Biopharmaceuticals Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.25.5 Sun pharma Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Biopharmaceuticals Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Biopharmaceuticals Players Market Share in 2021

3.2.2 Top 10 Biopharmaceuticals Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Biopharmaceuticals Players Head Office, Products and Services Provided

3.4 Biopharmaceuticals Mergers & Acquisitions

3.5 Biopharmaceuticals New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Biopharmaceuticals Revenue and Market Share by Type (2017-2022)

4.2 Global Biopharmaceuticals Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Biopharmaceuticals Revenue Market Share by Application (2017-2022)

5.2 Global Biopharmaceuticals Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Biopharmaceuticals Revenue by Type (2017-2028)

6.2 North America Biopharmaceuticals Revenue by Application (2017-2028)

6.3 North America Biopharmaceuticals Market Size by Country

6.3.1 North America Biopharmaceuticals Revenue by Country (2017-2028)

6.3.2 United States Biopharmaceuticals Market Size and Forecast (2017-2028)

6.3.3 Canada Biopharmaceuticals Market Size and Forecast (2017-2028)

6.3.4 Mexico Biopharmaceuticals Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Biopharmaceuticals Revenue by Type (2017-2028)

7.2 Europe Biopharmaceuticals Revenue by Application (2017-2028)

7.3 Europe Biopharmaceuticals Market Size by Country

7.3.1 Europe Biopharmaceuticals Revenue by Country (2017-2028)

7.3.2 Germany Biopharmaceuticals Market Size and Forecast (2017-2028)

7.3.3 France Biopharmaceuticals Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Biopharmaceuticals Market Size and Forecast (2017-2028)

7.3.5 Russia Biopharmaceuticals Market Size and Forecast (2017-2028)

7.3.6 Italy Biopharmaceuticals Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Biopharmaceuticals Revenue by Type (2017-2028)

8.2 Asia-Pacific Biopharmaceuticals Revenue by Application (2017-2028)

8.3 Asia-Pacific Biopharmaceuticals Market Size by Region

8.3.1 Asia-Pacific Biopharmaceuticals Revenue by Region (2017-2028)

8.3.2 China Biopharmaceuticals Market Size and Forecast (2017-2028)

8.3.3 Japan Biopharmaceuticals Market Size and Forecast (2017-2028)

8.3.4 South Korea Biopharmaceuticals Market Size and Forecast (2017-2028)

8.3.5 India Biopharmaceuticals Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Biopharmaceuticals Market Size and Forecast (2017-2028)

8.3.7 Australia Biopharmaceuticals Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Biopharmaceuticals Revenue by Type (2017-2028)

9.2 South America Biopharmaceuticals Revenue by Application (2017-2028)

9.3 South America Biopharmaceuticals Market Size by Country

9.3.1 South America Biopharmaceuticals Revenue by Country (2017-2028)

9.3.2 Brazil Biopharmaceuticals Market Size and Forecast (2017-2028)

9.3.3 Argentina Biopharmaceuticals Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Biopharmaceuticals Revenue by Type (2017-2028)

10.2 Middle East & Africa Biopharmaceuticals Revenue by Application (2017-2028)

10.3 Middle East & Africa Biopharmaceuticals Market Size by Country

10.3.1 Middle East & Africa Biopharmaceuticals Revenue by Country (2017-2028)

10.3.2 Turkey Biopharmaceuticals Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Biopharmaceuticals Market Size and Forecast (2017-2028)

10.3.4 UAE Biopharmaceuticals Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Biopharmaceuticals Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Biopharmaceuticals Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Biopharmaceuticals Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Biopharmaceuticals Revenue (USD Million) by Region (2017-2022)

Table 5. Global Biopharmaceuticals Revenue Market Share by Region (2023-2028)

Table 6. Roche Corporate Information, Head Office, and Major Competitors

Table 7. Roche Major Business

Table 8. Roche Biopharmaceuticals Product and Solutions

Table 9. Roche Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Amgen Corporate Information, Head Office, and Major Competitors

Table 11. Amgen Major Business

Table 12. Amgen Biopharmaceuticals Product and Solutions

Table 13. Amgen Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. AbbVie Corporate Information, Head Office, and Major Competitors

Table 15. AbbVie Major Business

Table 16. AbbVie Biopharmaceuticals Product and Solutions

Table 17. AbbVie Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Sanofi-Aventis Corporate Information, Head Office, and Major Competitors

Table 19. Sanofi-Aventis Major Business

Table 20. Sanofi-Aventis Biopharmaceuticals Product and Solutions

Table 21. Sanofi-Aventis Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 23. Johnson & Johnson Major Business

Table 24. Johnson & Johnson Biopharmaceuticals Product and Solutions

Table 25. Johnson & Johnson Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Pfizer Corporate Information, Head Office, and Major Competitors

Table 27. Pfizer Major Business

Table 28. Pfizer Biopharmaceuticals Product and Solutions

Table 29. Pfizer Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Novo Nordisk Corporate Information, Head Office, and Major Competitors

Table 31. Novo Nordisk Major Business

Table 32. Novo Nordisk Biopharmaceuticals Product and Solutions

Table 33. Novo Nordisk Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 35. Eli Lilly Major Business

Table 36. Eli Lilly Biopharmaceuticals Product and Solutions

Table 37. Eli Lilly Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Novartis Corporate Information, Head Office, and Major Competitors

Table 39. Novartis Major Business

Table 40. Novartis Biopharmaceuticals Product and Solutions

Table 41. Novartis Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Merck Corporate Information, Head Office, and Major Competitors

Table 43. Merck Major Business

Table 44. Merck Biopharmaceuticals Product and Solutions

Table 45. Merck Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Sun Corporate Information, Head Office, and Major Competitors

Table 47. Sun Major Business

Table 48. Sun Biopharmaceuticals Product and Solutions

Table 49. Sun Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. 3sbio Corporate Information, Head Office, and Major Competitors

Table 51. 3sbio Major Business

Table 52. 3sbio Biopharmaceuticals Product and Solutions

Table 53. 3sbio Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Changchun High Tech Corporate Information, Head Office, and Major Competitors

Table 55. Changchun High Tech Major Business

Table 56. Changchun High Tech Biopharmaceuticals Product and Solutions

Table 57. Changchun High Tech Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. CP Guojian Corporate Information, Head Office, and Major Competitors

Table 59. CP Guojian Major Business

Table 60. CP Guojian Biopharmaceuticals Product and Solutions

Table 61. CP Guojian Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Biotech Corporate Information, Head Office, and Major Competitors

Table 63. Biotech Major Business

Table 64. Biotech Biopharmaceuticals Product and Solutions

Table 65. Biotech Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Gelgen Corporate Information, Head Office, and Major Competitors

Table 67. Gelgen Major Business

Table 68. Gelgen Biopharmaceuticals Product and Solutions

Table 69. Gelgen Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Innovent Corporate Information, Head Office, and Major Competitors

Table 71. Innovent Major Business

Table 72. Innovent Biopharmaceuticals Product and Solutions

Table 73. Innovent Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Dong Bao Corporate Information, Head Office, and Major Competitors

Table 75. Dong Bao Major Business

Table 76. Dong Bao Biopharmaceuticals Product and Solutions

Table 77. Dong Bao Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Ganlee Corporate Information, Head Office, and Major Competitors

Table 79. Ganlee Major Business

Table 80. Ganlee Biopharmaceuticals Product and Solutions

Table 81. Ganlee Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. United Laboratories Corporate Information, Head Office, and Major Competitors

Table 83. United Laboratories Major Business

Table 84. United Laboratories Biopharmaceuticals Product and Solutions

Table 85. United Laboratories Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 86. SANDOZ (NOVARTIS) Corporate Information, Head Office, and Major Competitors

Table 87. SANDOZ (NOVARTIS) Major Business

Table 88. SANDOZ (NOVARTIS) Biopharmaceuticals Product and Solutions

Table 89. SANDOZ (NOVARTIS) Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 90. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 91. Teva Pharmaceutical Major Business

Table 92. Teva Pharmaceutical Biopharmaceuticals Product and Solutions

Table 93. Teva Pharmaceutical Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 94. Hospira （Pfizer） Corporate Information, Head Office, and Major Competitors

Table 95. Hospira （Pfizer） Major Business

Table 96. Hospira （Pfizer） Biopharmaceuticals Product and Solutions

Table 97. Hospira （Pfizer） Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 98. MYLAN Corporate Information, Head Office, and Major Competitors

Table 99. MYLAN Major Business

Table 100. MYLAN Biopharmaceuticals Product and Solutions

Table 101. MYLAN Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 102. Sun pharma Corporate Information, Head Office, and Major Competitors

Table 103. Sun pharma Major Business

Table 104. Sun pharma Biopharmaceuticals Product and Solutions

Table 105. Sun pharma Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 106. Global Biopharmaceuticals Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 107. Global Biopharmaceuticals Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 108. Breakdown of Biopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3)

Table 109. Biopharmaceuticals Players Head Office, Products and Services Provided

Table 110. Biopharmaceuticals Mergers & Acquisitions in the Past Five Years

Table 111. Biopharmaceuticals New Entrants and Expansion Plans

Table 112. Global Biopharmaceuticals Revenue (USD Million) by Type (2017-2022)

Table 113. Global Biopharmaceuticals Revenue Share by Type (2017-2022)

Table 114. Global Biopharmaceuticals Revenue Forecast by Type (2023-2028)

Table 115. Global Biopharmaceuticals Revenue by Application (2017-2022)

Table 116. Global Biopharmaceuticals Revenue Forecast by Application (2023-2028)

Table 117. North America Biopharmaceuticals Revenue by Type (2017-2022) & (USD Million)

Table 118. North America Biopharmaceuticals Revenue by Type (2023-2028) & (USD Million)

Table 119. North America Biopharmaceuticals Revenue by Application (2017-2022) & (USD Million)

Table 120. North America Biopharmaceuticals Revenue by Application (2023-2028) & (USD Million)

Table 121. North America Biopharmaceuticals Revenue by Country (2017-2022) & (USD Million)

Table 122. North America Biopharmaceuticals Revenue by Country (2023-2028) & (USD Million)

Table 123. Europe Biopharmaceuticals Revenue by Type (2017-2022) & (USD Million)

Table 124. Europe Biopharmaceuticals Revenue by Type (2023-2028) & (USD Million)

Table 125. Europe Biopharmaceuticals Revenue by Application (2017-2022) & (USD Million)

Table 126. Europe Biopharmaceuticals Revenue by Application (2023-2028) & (USD Million)

Table 127. Europe Biopharmaceuticals Revenue by Country (2017-2022) & (USD Million)

Table 128. Europe Biopharmaceuticals Revenue by Country (2023-2028) & (USD Million)

Table 129. Asia-Pacific Biopharmaceuticals Revenue by Type (2017-2022) & (USD Million)

Table 130. Asia-Pacific Biopharmaceuticals Revenue by Type (2023-2028) & (USD Million)

Table 131. Asia-Pacific Biopharmaceuticals Revenue by Application (2017-2022) & (USD Million)

Table 132. Asia-Pacific Biopharmaceuticals Revenue by Application (2023-2028) & (USD Million)

Table 133. Asia-Pacific Biopharmaceuticals Revenue by Region (2017-2022) & (USD Million)

Table 134. Asia-Pacific Biopharmaceuticals Revenue by Region (2023-2028) & (USD Million)

Table 135. South America Biopharmaceuticals Revenue by Type (2017-2022) & (USD Million)

Table 136. South America Biopharmaceuticals Revenue by Type (2023-2028) & (USD Million)

Table 137. South America Biopharmaceuticals Revenue by Application (2017-2022) & (USD Million)

Table 138. South America Biopharmaceuticals Revenue by Application (2023-2028) & (USD Million)

Table 139. South America Biopharmaceuticals Revenue by Country (2017-2022) & (USD Million)

Table 140. South America Biopharmaceuticals Revenue by Country (2023-2028) & (USD Million)

Table 141. Middle East & Africa Biopharmaceuticals Revenue by Type (2017-2022) & (USD Million)

Table 142. Middle East & Africa Biopharmaceuticals Revenue by Type (2023-2028) & (USD Million)

Table 143. Middle East & Africa Biopharmaceuticals Revenue by Application (2017-2022) & (USD Million)

Table 144. Middle East & Africa Biopharmaceuticals Revenue by Application (2023-2028) & (USD Million)

Table 145. Middle East & Africa Biopharmaceuticals Revenue by Country (2017-2022) & (USD Million)

Table 146. Middle East & Africa Biopharmaceuticals Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Biopharmaceuticals Picture

Figure 2. Global Biopharmaceuticals Revenue Market Share by Type in 2021

Figure 3. Monoclonal Antibodies

Figure 4. Interferon

Figure 5. Colony-Stimulating Factor

Figure 6. Erythropoietin

Figure 7. Insulin

Figure 8. Vaccines

Figure 9. Growth Hormones

Figure 10. Others

Figure 11. Biopharmaceuticals Revenue Market Share by Application in 2021

Figure 12. Tumor Picture

Figure 13. Diabetes Picture

Figure 14. Cardiovascular Picture

Figure 15. Hemophilia Picture

Figure 16. Others Picture

Figure 17. Global Biopharmaceuticals Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 18. Global Biopharmaceuticals Revenue and Forecast (2017-2028) & (USD Million)

Figure 19. Global Biopharmaceuticals Revenue Market Share by Region (2017-2028)

Figure 20. Global Biopharmaceuticals Revenue Market Share by Region in 2021

Figure 21. North America Biopharmaceuticals Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. Europe Biopharmaceuticals Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. Asia-Pacific Biopharmaceuticals Revenue (USD Million) and Growth Rate (2017-2028)

Figure 24. South America Biopharmaceuticals Revenue (USD Million) and Growth Rate (2017-2028)

Figure 25. Middle East and Africa Biopharmaceuticals Revenue (USD Million) and Growth Rate (2017-2028)

Figure 26. Biopharmaceuticals Market Drivers

Figure 27. Biopharmaceuticals Market Restraints

Figure 28. Biopharmaceuticals Market Trends

Figure 29. Roche Recent Developments and Future Plans

Figure 30. Amgen Recent Developments and Future Plans

Figure 31. AbbVie Recent Developments and Future Plans

Figure 32. Sanofi-Aventis Recent Developments and Future Plans

Figure 33. Johnson & Johnson Recent Developments and Future Plans

Figure 34. Pfizer Recent Developments and Future Plans

Figure 35. Novo Nordisk Recent Developments and Future Plans

Figure 36. Eli Lilly Recent Developments and Future Plans

Figure 37. Novartis Recent Developments and Future Plans

Figure 38. Merck Recent Developments and Future Plans

Figure 39. Sun Recent Developments and Future Plans

Figure 40. 3sbio Recent Developments and Future Plans

Figure 41. Changchun High Tech Recent Developments and Future Plans

Figure 42. CP Guojian Recent Developments and Future Plans

Figure 43. Biotech Recent Developments and Future Plans

Figure 44. Gelgen Recent Developments and Future Plans

Figure 45. Innovent Recent Developments and Future Plans

Figure 46. Dong Bao Recent Developments and Future Plans

Figure 47. Ganlee Recent Developments and Future Plans

Figure 48. United Laboratories Recent Developments and Future Plans

Figure 49. SANDOZ (NOVARTIS) Recent Developments and Future Plans

Figure 50. Teva Pharmaceutical Recent Developments and Future Plans

Figure 51. Hospira （Pfizer） Recent Developments and Future Plans

Figure 52. MYLAN Recent Developments and Future Plans

Figure 53. Sun pharma Recent Developments and Future Plans

Figure 54. Global Biopharmaceuticals Revenue Share by Players in 2021

Figure 55. Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 56. Global Top 3 Players Biopharmaceuticals Revenue Market Share in 2021

Figure 57. Global Top 10 Players Biopharmaceuticals Revenue Market Share in 2021

Figure 58. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 59. Global Biopharmaceuticals Revenue Share by Type in 2021

Figure 60. Global Biopharmaceuticals Market Share Forecast by Type (2023-2028)

Figure 61. Global Biopharmaceuticals Revenue Share by Application in 2021

Figure 62. Global Biopharmaceuticals Market Share Forecast by Application (2023-2028)

Figure 63. North America Biopharmaceuticals Sales Market Share by Type (2017-2028)

Figure 64. North America Biopharmaceuticals Sales Market Share by Application (2017-2028)

Figure 65. North America Biopharmaceuticals Revenue Market Share by Country (2017-2028)

Figure 66. United States Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Canada Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Mexico Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Europe Biopharmaceuticals Sales Market Share by Type (2017-2028)

Figure 70. Europe Biopharmaceuticals Sales Market Share by Application (2017-2028)

Figure 71. Europe Biopharmaceuticals Revenue Market Share by Country (2017-2028)

Figure 72. Germany Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. France Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. United Kingdom Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Russia Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Italy Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Asia-Pacific Biopharmaceuticals Sales Market Share by Type (2017-2028)

Figure 78. Asia-Pacific Biopharmaceuticals Sales Market Share by Application (2017-2028)

Figure 79. Asia-Pacific Biopharmaceuticals Revenue Market Share by Region (2017-2028)

Figure 80. China Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Japan Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. South Korea Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. India Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 84. Southeast Asia Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 85. Australia Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 86. South America Biopharmaceuticals Sales Market Share by Type (2017-2028)

Figure 87. South America Biopharmaceuticals Sales Market Share by Application (2017-2028)

Figure 88. South America Biopharmaceuticals Revenue Market Share by Country (2017-2028)

Figure 89. Brazil Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 90. Argentina Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 91. Middle East and Africa Biopharmaceuticals Sales Market Share by Type (2017-2028)

Figure 92. Middle East and Africa Biopharmaceuticals Sales Market Share by Application (2017-2028)

Figure 93. Middle East and Africa Biopharmaceuticals Revenue Market Share by Country (2017-2028)

Figure 94. Turkey Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 95. Saudi Arabia Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 96. UAE Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 97. Methodology

Figure 98. Research Process and Data Source